USA
Research/ Prototyping
DHA Enterprise- Wide Commercial Solutions Opening ( CSO) - September 30, 2026: Amendment 01: Updates Section 14 of the CSO. This announcement establishes the general competitive procedures the Government will utilize to award FAR- based contracts pursuant to 10 U. S. C. & sect; **** and 10 U. S. C
Commercial Solutions Opening for Defense Health Agency enterprise- wide commercial solutions Commercial products, commercial services, non- developmental items, electronic health record, operational medicine, clinical support, logistics, surveillance, business systems, enterprise data, analytics, decision- support capabilities, medical digital solutions, medical services, medical products
AI helper
DHA establishes a Commercial Solutions Opening (CSO) to award FAR-based contracts and Other Transaction agreements for commercial solutions in medical digital solutions, medical services, and medical products. The CSO is open from August 7, 2026 to August 6, 2027. Submissions are evaluated in phases: pitch/white paper, oral presentation/demonstration, and full proposal. Evaluation criteria include commercial feasibility, technical merit, technology readiness level, and cost-effectiveness. Multiple awards may be made. Contracts will be firm-fixed-price or firm-fixed-price with performance incentives. Offerors must meet statutory criteria for prototype OTA awards. No costs for preparation will be paid.
The government will evaluate submissions based on their commercial feasibility, technical merit, technology readiness level, and cost-effectiveness. The government will evaluate submissions based on their commercial feasibility, technical merit, technology readiness level, and cost-effectiveness.
Offerors must meet at least one of the statutory criteria in 10 **** to be eligible for a prototype OTA award. to be eligible for a prototype otaaward under 10 ****, offerors must meet at least one of the statutory criteriain 10 ****.